The subscription price for Odinwell's warrants of series TO 2 has been set at SEK 0.164 per share ahead of the subscription period, which begins on May 18 and runs until June 1, 2026, according to a press release.The price corresponds to 70 percent of the volume-weighted average price of the share during the measurement period May 4–15, when the average amounted to about SEK 0.234. If fully subscribed, the company is expected to receive about SEK 0.85 million before issue costs. Dilution for shareholders who do not participate will be about 9.3 percent if all warrants are subscribed. Odinwell states that the main owner Nestero Holding, as well as board members and members of management, have submitted subscription commitments corresponding to about 13.4 percent of the outstanding TO 2, or around SEK 0.11 million. "Ahead of the exercise period for TO 2, I can note that we are delivering on the goals we set in connection with the rights issue in spring 2025. We have moved from technology development to actual product sales. Recently, we received our first order, two handheld instruments to the Swedish University of Agricultural Sciences, which is concrete proof that the market is demanding our technology. Pilot production is under way and veterinary medicine has been integrated into our development plan as a path to market in the shorter term, without deviating from our long-term strategy on the human side," says CEO Marcus Andersson in a comment. He continues. "At the same time, we are actively working to establish a long-term financing solution that gives the company the right conditions to complete the journey toward product launch and an industrial partnership. TO 2 is an important step in that work, and we are grateful for the continued trust from our shareholders."